In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pyrosequencing buys Biotage from Dyax

Executive Summary

Pyrosequencing (genetic analysis systems and medicinal chemistry research) has acquired Dyax Corp.'s wholly owned subsidiary Biotage LLC (drug discovery systems and consumables) for net cash of about SEK230.5mm ($30mm) and $5mm in Biotage debt.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash
    • Includes Contract
    • Intra-Biotech Deal

Related Companies